Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Routine Use of Gemtuzumab Ozogamicin in 7+3-Based Inductions for All "Non-Adverse" Risk AML

Gavin Hui, MD, Abdullah Ladha, MD, Edna Cheung, PharmD, Caroline Berube, MD, Steven Coutre, MD, Jason Gotlib, MD MS, Michaela Liedtke, MD, Tian Y Zhang, MD PhD, Lori S. Muffly, MD MS, Gabriel N. Mannis, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-142691

Published: 2020

Journal Articles

Prochemerin cleavage by factor XIa links coagulation and inflammation

Xiaomei Ge, Yasuto Yamaguchi, Lei Zhao, Loredana Bury, Paolo Gresele, Caroline Berube, Lawrence L. Leung, John Morser

Blood (2018) 131 (3): 353–364.

https://doi.org/10.1182/blood-2017-07-792580

Published: 2018

Includes: Supplemental data

Journal Articles

Using Electronic Best Practice Alerts to Improve Thrombophilia Testing Based on ASH Choosing Wisely Guidelines

Tomi Jun, MD, Henry Kwang, MD, Eric Mou, MD, Caroline Berube, MD, Neil Shah, MD, Rajani Kaimal, MS, Jason Bentley, PhD, Neera Ahuja, MD, Lisa Shieh, MD, Jason Hom, MD

Blood (2017) 130 (Supplement 1): 3355.

https://doi.org/10.1182/blood.V130.Suppl_1.3355.3355

Published: 2017

Journal Articles

Prevalence and Financial Impact of Inappropriate Thrombophilia Testing in the Inpatient Hospital Setting: A Retrospective Analysis

Eric Mou, MD, Henry Kwang, MD, Jason Hom, MD, Lisa Shieh, MD, Neera Ahuja, MD, Stephanie Harman, MD, Tyler Johnson, MD, Andre Kumar, MD, Neil Shah, MD, Ronald Witteles, MD, Caroline Berube, MD FRCP(C)

Blood (2016) 128 (22): 2330.

https://doi.org/10.1182/blood.V128.22.2330.2330

Published: 2016

Journal Articles

Change In Albumin Levels During Induction Predicts Survival Outcomes In Adult Acute Lymphoblastic Leukemia

Kimberly Komatsubara, MD, Tamara J. Dunn, MD, Daniel J Lee, MD, Steven E. Coutre, MD, Caroline Berube, MD, Jason Gotlib, MD, MS, Bruno C. Medeiros, MD, Michaela Liedtke, MD

Blood (2013) 122 (21): 1403.

https://doi.org/10.1182/blood.V122.21.1403.1403

Published: 2013

Journal Articles

Amrubicin, a Novel Investigational Anthracycline, in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study

Shira N. Dinner, MD, Tamara J. Dunn, MD, Bruno C. Medeiros, MD, Steven E. Coutre, MD, Caroline Berube, MD, Jason Gotlib, M.D., M.S., Michaela Liedtke, MD

Blood (2012) 120 (21): 4027.

https://doi.org/10.1182/blood.V120.21.4027.4027

Published: 2012

Journal Articles

A Phase I/II Study of Bortezomib (VELCADE) in Combination with Pralatrexate in Relapsed/Refractory Multiple Myeloma

Tamara J. Dunn, MD, Shira N. Dinner, MD, Caroline Berube, MD, Jason Gotlib, MD, MS, Steven E. Coutre, MD, Bruno C. Medeiros, MD, Michaela Liedtke, MD

Blood (2012) 120 (21): 4304.

https://doi.org/10.1182/blood.V120.21.4304.4304

Published: 2012

Journal Articles

Temozolomide In Acute Myeloid Leukemia: A MGMT Promoter Methylation Status–Based Treatment Stratification

Bruno C. Medeiros, MD, Holbrook E Kohrt, MD, Richa Rajwanshi, Jason Gotlib, M.D., M.S., Steven Coutre, Michaela Liedtke, MD, Caroline Berube, MD, Melody Zhang, Daniel A. Arber, MD, James L. Zehnder, M.D.

Blood (2010) 116 (21): 3313.

https://doi.org/10.1182/blood.V116.21.3313.3313

Published: 2010

Journal Articles

A Phase I Study of Sequential Azacitidine and Lenalidomide for Elderly Patients with Acute Myeloid Leukemia (AML)

Daniel A Pollyea, MD, Holbrook E Kohrt, MD, Leonel Gallegos, MD, Caroline Berube, MD, Steven Coutre, MD, Jason Gotlib, M.D., M.S., Michaela Liedtke, MD, Beverly S. Mitchell, MD, Bruno C. Medeiros, MD

Blood (2010) 116 (21): 3288.

https://doi.org/10.1182/blood.V116.21.3288.3288

Published: 2010

Journal Articles

The Impact of Distance to Treatment Center on the Outcome of AML

Bruno C. Medeiros, MD, Tamara J. Dunn, MD, Holbrook E Kohrt, MD, Steven Coutre, Jason Gotlib, M.D., M.S., Michaela Liedtke, MD, Caroline Berube, MD, Ash A. Alizadeh, MD/PhD

Blood (2010) 116 (21): 4742.

https://doi.org/10.1182/blood.V116.21.4742.4742

Published: 2010

NARROW

Routine Use of Gemtuzumab Ozogamicin in 7+3-Based Inductions for All "Non-Adverse" Risk AML

Prochemerin cleavage by factor XIa links coagulation and inflammation

Using Electronic Best Practice Alerts to Improve Thrombophilia Testing Based on ASH Choosing Wisely Guidelines

Prevalence and Financial Impact of Inappropriate Thrombophilia Testing in the Inpatient Hospital Setting: A Retrospective Analysis

Change In Albumin Levels During Induction Predicts Survival Outcomes In Adult Acute Lymphoblastic Leukemia

Amrubicin, a Novel Investigational Anthracycline, in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study

A Phase I/II Study of Bortezomib (VELCADE) in Combination with Pralatrexate in Relapsed/Refractory Multiple Myeloma

Temozolomide In Acute Myeloid Leukemia: A MGMT Promoter Methylation Status–Based Treatment Stratification

A Phase I Study of Sequential Azacitidine and Lenalidomide for Elderly Patients with Acute Myeloid Leukemia (AML)

The Impact of Distance to Treatment Center on the Outcome of AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only